Triggering Receptor Expressed on Myeloid Cells-1 in Neutrophil Inflammatory Responses: Differential Regulation of Activation and Survival

Polymorphonuclear neutrophils (PMN) are crucial in the innate host defense by their ability to rapidly accumulate in inflamed tissues and clear a site of infection from microbial pathogens by their potent effector mechanisms. The triggering receptor expressed on myeloid cells (TREM)-1 is a recently described activating receptor on PMN with an important role in inflammation. However, the effects of TREM-1 stimulation on a cellular level remain to be further defined. To characterize TREM-1-mediated activation of human PMN, we evaluated the effect of receptor ligation on PMN effector functions. Activation via TREM-1 induces immediate degranulation of neutrophilic granules resulting in the release of IL-8, respiratory burst, and phagocytosis. TREM-1 ligation synergizes with the activation by the Toll-like receptors (TLR) ligands LPS, Pam3Cys, and R-848. In contrast, no synergy between TREM-1- and TLR-mediated stimulation was observed concerning PMN survival, whereas TLR-mediated stimuli protect PMN from apoptosis, concurrent TREM-1 activation neutralizes these anti-apoptotic effects. These results give a new perspective for the regulation of neutrophil inflammatory responses emphasizing the importance of TREM-1 in innate immunity.

[1]  M. C. Cardoso,et al.  Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. , 2003, Blood.

[2]  H. Simon.  Neutrophil apoptosis pathways and their modifications in inflammation , 2003, Immunological reviews.

[3]  S. Foster,et al.  Selective Roles for Toll-Like Receptor (TLR)2 and TLR4 in the Regulation of Neutrophil Activation and Life Span1 , 2003, The Journal of Immunology.

[4]  C. Buonsanti,et al.  A Role for Triggering Receptor Expressed on Myeloid Cells-1 in Host Defense During the Early-Induced and Adaptive Phases of the Immune Response1 , 2003, The Journal of Immunology.

[5]  H. Rammensee,et al.  The heat shock protein Gp96 binds to human neutrophils and monocytes and stimulates effector functions. , 2003, Blood.

[6]  S. Akira,et al.  Recognition of pathogen-associated molecular patterns by TLR family. , 2003, Immunology letters.

[7]  John Savill,et al.  A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.

[8]  P. Vignais.  The superoxide-generating NADPH oxidase: structural aspects and activation mechanism , 2002, Cellular and Molecular Life Sciences CMLS.

[9]  P. Newburger,et al.  Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. , 2002, Blood.

[10]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[11]  G. Fernández,et al.  Soluble Fibrinogen Modulates Neutrophil Functionality Through the Activation of an Extracellular Signal-Regulated Kinase-Dependent Pathway1 , 2002, The Journal of Immunology.

[12]  S. de Vos,et al.  Ph(+) acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation. , 2002, Blood.

[13]  S. Grinstein,et al.  Phagocytosis and innate immunity. , 2002, Current opinion in immunology.

[14]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[15]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[16]  C. Harding,et al.  Mycobacterium tuberculosis 19-kDa Lipoprotein Promotes Neutrophil Activation1 , 2001, The Journal of Immunology.

[17]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[18]  H. Simon,et al.  CD137 activation abrogates granulocyte‐macrophage colony‐stimulating factor‐mediated anti‐apoptosis in neutrophils , 2000, European journal of immunology.

[19]  A. Halstensen,et al.  Phagocytosis: measurement by flow cytometry. , 2000, Journal of immunological methods.

[20]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[21]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells , 2000 .

[22]  P. Vogt,et al.  Cytokine-mediated Bax deficiency and consequent delayed neutrophil apoptosis: a general mechanism to accumulate effector cells in inflammation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Haslett,et al.  Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. , 1997, Blood.

[24]  P. Ehrlich.  Granules of the Human Neutrophilic Polymorphonuclear Leukocyte , 1997 .

[25]  G. Downey,et al.  Intracellular signaling in neutrophil priming and activation. , 1995, Seminars in cell biology.

[26]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[27]  A. Ben-Baruch,et al.  Signals and Receptors Involved in Recruitment of Inflammatory Cells (*) , 1995, The Journal of Biological Chemistry.

[28]  J. Oppenheim,et al.  Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. , 1992, Immunology today.

[29]  W. Bessler,et al.  Synthesis of novel immunologically active tripalmitoyl-S-glycerylcysteinyl lipopeptides as useful intermediates for immunogen preparations. , 2009, International journal of peptide and protein research.

[30]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[31]  G. Sonnenfeld,et al.  The effect of tumor necrosis factor-a and interferon-? on neutrophil function , 1989 .

[32]  W. Bodmer,et al.  Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2 , 1978, Nature.

[33]  L. Harker,et al.  Neutrophil kinetics in man. , 1976, The Journal of clinical investigation.

[34]  R. van Furth,et al.  QUANTITATIVE STUDY ON THE PRODUCTION AND KINETICS OF MONONUCLEAR PHAGOCYTES DURING AN ACUTE INFLAMMATORY REACTION , 1973, The Journal of experimental medicine.